Correction: A CD80-Biased CTLA4-Ig Fusion Protein with Superior In Vivo Efficacy by Simultaneous Engineering of Affinity, Selectivity, Stability, and FcRn Binding.

Douthwaite, Julie; Moisan, Jacques; Privezentzev, Cyril; Soskic, Blagoje; Sabbah, Shereen; Cohen, Suzanne; Collinson, Andie; England, Elizabeth; Huntington, Catherine; Kemp, Ben; Zhuang, Li; Hudak, Suzanne; Rees, D Gareth; Goldberg, Debbie; Barton, Chris; Chang, Linda; Vainshtein, Inna; Liang, Meina; Iciek, Laurie; Ambery, Philip; Peakman, Mark; Vaughan, Tristan J; Tree, Tim I M; Sansom, David M; Bowen, Michael A; Minter, Ralph R; Jermutus, Lutz

Douthwaite, Julie; Moisan, Jacques; Privezentzev, Cyril; Soskic, Blagoje; Sabbah, Shereen; Cohen, Suzanne; Collinson, Andie; England, Elizabeth; Huntington, Catherine; Kemp, Ben; Zhuang, Li; Hudak, Suzanne; Rees, D Gareth; Goldberg, Debbie; Barton, Chris; Chang, Linda; Vainshtein, Inna; Liang, Meina; Iciek, Laurie; Ambery, Philip; Peakman, Mark; Vaughan, Tristan J; Tree, Tim I M; Sansom, David M; Bowen, Michael A; Minter, Ralph R; Jermutus, Lutz.

J Immunol ; 199(5): 1943, 2017 09 01.

Article en En | MEDLINE | ID: mdl-28827388

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2017 Tipo del documento: Article